Hospira Blood Sets Recalled Due to Potential Bag Puncture Risk
Hospira is recalling 1,152 blood sets because the piercing pin may puncture the outer wall of blood bags during insertion.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "It was discovered that there was a potential for the piercing pin on certain Hospira blood sets to puncture the outer wall of blood bags during insertion of the pin into the blood bag."
Plain-English summary
Hospira Inc. is recalling 1,152 units of List No. 14203-28 Blood Sets. These products are designed for blood product administration and feature a 200-micron filter and non-DEHP components. The affected units were manufactured in Costa Rica and distributed nationwide in the United States, Puerto Rico, and internationally to Costa Rica.
The recall was initiated because it was discovered that there is a potential for the piercing pin on certain blood sets to puncture the outer wall of blood bags during insertion of the pin into the bag. This defect could compromise the integrity of the blood product container.
The affected lot numbers are 030895H and 961465H. Consumers and healthcare providers should stop using these specific blood sets and contact Hospira Inc. for further instructions or replacement.
The recalled product
- Product
- List No. 14203-28; BLOOD SET; 200 Micron Filter, 80 Inch, Non-DEHP; For Blood Product Administration; Made in Costa Rica; Product Inquiries should be directed to Hospira., Inc., Lake Forrest, IL 60045 USA Hospira Blood sets are designed for Blood Product Administration
- Manufacturer
- Hospira Inc.
- Affected units
- 1,152
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- List Number: 14203-28
- Lot Numbers: 030895H
- 961465H
Distribution
Part of a larger recall action
This product is one of 9 recalled by Hospira Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 9 products in this recall →Related recalls
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · structural defect
See all →- SevereVolvo Recalls EX30 and EX30CC Vehicles for Head Restraint Defect
NHTSA · 2026-10-09
- Severe
- SevereONTHEWEI Recalls Baby Bath Seats Due to Drowning Risk
CPSC · 2026-10-08
- SevereDecathlon Recalls Van Rysel GRVL AF Bicycles Due to Crash Hazard
CPSC · 2026-10-08
- SevereSpectrum Medical Recalls Quantum PureFlow Heat Exchangers Due to Leak Risk
FDA (Devices) · 2026-10-07
Similar recalls
- ModerateHospira Recalls LifeShield Blood Sets Due to Assembly Errors
FDA (Devices) · 2014-03-12
- SevereHospira Recalls Lactated Ringer's Injection Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SevereHospira Recalls PlumSet IV Administration Sets Due to Fluid Leakage
FDA (Devices) · 2016-07-06
- HighHospira Recalls Plum A+ Infusion Systems Due to Broken Sensor Pin Risk
FDA (Devices) · 2013-11-20
- SevereHospira Recalls 5% Dextrose Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SevereHospira Recalls Lactated Ringer's and 5% Dextrose Injection Bags
FDA (Drugs) · 2014-12-03